CRISPR and CRISPR-Associated (Cas) Genes

Clustered regularly interspaced short palindromic repeats (CRISPR) are segments of prokaryotic DNA containing short repetitions of base sequences. Each repetition is followed by short segments of “spacer DNA” from previous exposures to a bacteriophage virus or plasmid. The CRISPR/Cas system is a prokaryotic immune system that confers resistance to foreign genetic elements such as those present within plasmids and phages, and provides a form of acquired immunity. CRISPR associated proteins (Cas) use the CRISPR spacers to recognize and cut these exogenous genetic elements in a manner analogous to RNA interference in eukaryotic organisms. CRISPRs are found in approximately 40% of sequenced bacterial genomes and 90% of sequenced archaea. CRISPR And CRISPR-Associated (Cas) Genes industry is relatively concentrated, manufacturers are mostly in the Europe and North America. Among them, North America region accounted for more than 45.70% of the total market of global CRISPR And CRISPR-Associated (Cas) Genes.

Market Analysis and Insights:

Global CRISPR and CRISPR-Associated (Cas) Genes Market The global CRISPR and CRISPR-Associated (Cas) Genes market size is projected to reach US$ 7696.7 million by 2026, from US$ 1022.2 million in 2019, at a CAGR of 40.0% during 2021-2026.

Get Sample Copy of This Report @

www.qyresearch.com/sample-form/form/2634255/global-crispr-and-crispr-associated-cas-genes-market

Global CRISPR and CRISPR-Associated (Cas) Genes Scope and Segment CRISPR and CRISPR-Associated (Cas) Genes market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global CRISPR and CRISPR-Associated (Cas) Genes market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2016-2027. The following manufacturers are covered in this report:, Caribou Biosciences, Addgene, CRISPR THERAPEUTICS, Merck KGaA, Mirus Bio LLC, Editas Medicine, Takara Bio USA, Thermo Fisher Scientific, Horizon Discovery Group, Intellia Therapeutics, GE Healthcare Dharmacon

CRISPR and CRISPR-Associated (Cas) Genes Breakdown Data by Type

Genome Editing, Genetic Engineering, gRNA Database/Gene Librar, CRISPR Plasmid, Human Stem Cells, Genetically Modified Organisms/Crops, Cell Line Engineering

CRISPR and CRISPR-Associated (Cas) Genes Breakdown Data by Application

Biotechnology Companies, Pharmaceutical Companies, Academic Institutes, Research and Development Institutes Regional and Country-level Analysis The CRISPR and CRISPR-Associated (Cas) Genes market is analysed and market size information is provided by regions (countries). The key regions covered in the CRISPR and CRISPR-Associated (Cas) Genes market report are North America, Europe, China and Japan. It also covers key regions (countries), viz, the U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc. The report includes country-wise and region-wise market size for the period 2016-2027. It also includes market size and forecast by Type, and by Application segment in terms of production capacity, price and revenue for the period 2016-2027. Competitive Landscape and CRISPR and CRISPR-Associated (Cas) Genes Market Share Analysis

Get Full Report In Your Inbox Within 24 Hours at USD(4900):

www.https://www.qyresearch.com/settlement/pre/d1a5b6a646852e06dae8f328580321bc,0,1,global-crispr-and-crispr-associated-cas-genes-market

Table of Contents

1 Study Coverage 1.1 CRISPR and CRISPR-Associated (Cas) Genes Product Introduction 1.2 Market by Type
1.2.1 Global CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth Rate by Type
1.4.2 Genome Editing
1.4.3 Genetic Engineering
1.2.4 gRNA Database/Gene Librar
1.2.5 CRISPR Plasmid
1.2.6 Human Stem Cells
1.2.7 Genetically Modified Organisms/Crops
1.2.8 Cell Line Engineering 1.3 Market by Application
1.3.1 Global CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth Rate by Application
1.3.2 Biotechnology Companies
1.3.3 Pharmaceutical Companies
1.3.4 Academic Institutes
1.3.5 Research and Development Institutes 1.4 Study Objectives 1.5 Years Considered 2 Executive Summary 2.1 Global CRISPR and CRISPR-Associated (Cas) Genes Sales Estimates and Forecasts 2016-2027 2.2 Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Estimates and Forecasts 2016-2027 2.3 Global CRISPR and CRISPR-Associated (Cas) Genes Revenue by Region: 2016 VS 2021 VS 2027 2.4 Global Top CRISPR and CRISPR-Associated (Cas) Genes Regions by Sales
2.4.1 Global Top CRISPR and CRISPR-Associated (Cas) Genes Regions by Sales (2016-2021)
2.4.2 Global Top CRISPR and CRISPR-Associated (Cas) Genes Regions by Sales (2022-2027) 2.5 Global Top CRISPR and CRISPR-Associated (Cas) Genes Regions by Revenue
2.5.1 Global Top CRISPR and CRISPR-Associated (Cas) Genes Regions by Revenue (2016-2021)
2.5.2 Global Top CRISPR and CRISPR-Associated (Cas) Genes Regions by Revenue (2022-2027) 2.6 North America 2.7 Europe 2.8 Asia-Pacific 2.9 Latin America 2.10 Middle East & Africa 3 Competition by Manufacturers 3.1 Global CRISPR and CRISPR-Associated (Cas) Genes Sales by Manufacturers
3.1.1 Global Top CRISPR and CRISPR-Associated (Cas) Genes Manufacturers by Sales (2016-2021)
3.1.2 Global Top CRISPR and CRISPR-Associated (Cas) Genes Manufacturers Market Share by Sales (2016-2021)
3.1.3 Global Top 10 and Top 5 Companies by CRISPR and CRISPR-Associated (Cas) Genes Sales in 2020 3.2 Global CRISPR and CRISPR-Associated (Cas) Genes Revenue by Manufacturers
3.2.1 Global Top CRISPR and CRISPR-Associated (Cas) Genes Manufacturers by Revenue (2016-2021)
3.2.2 Global Top CRISPR and CRISPR-Associated (Cas) Genes Manufacturers Market Share by Revenue (2016-2021)
3.2.3 Global Top 10 and Top 5 Companies by CRISPR and CRISPR-Associated (Cas) Genes Revenue in 2020 3.3 Global CRISPR and CRISPR-Associated (Cas) Genes Sales Price by Manufacturers 3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global CRISPR and CRISPR-Associated (Cas) Genes Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global CRISPR and CRISPR-Associated (Cas) Genes Manufacturers Geographical Distribution 3.5 Mergers & Acquisitions, Expansion Plans 4 Market Size by Type 4.1 Global CRISPR and CRISPR-Associated (Cas) Genes Sales by Type
4.1.1 Global CRISPR and CRISPR-Associated (Cas) Genes Historical Sales by Type (2016-2021)
4.1.2 Global CRISPR and CRISPR-Associated (Cas) Genes Forecasted Sales by Type (2022-2027)
4.1.3 Global CRISPR and CRISPR-Associated (Cas) Genes Sales Market Share by Type (2016-2027) 4.2 Global CRISPR and CRISPR-Associated (Cas) Genes Revenue by Type
4.2.1 Global CRISPR and CRISPR-Associated (Cas) Genes Historical Revenue by Type (2016-2021)
4.2.2 Global CRISPR and CRISPR-Associated (Cas) Genes Forecasted Revenue by Type (2022-2027)
4.2.3 Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Type (2016-2027) 4.3 Global CRISPR and CRISPR-Associated (Cas) Genes Price by Type
4.3.1 Global CRISPR and CRISPR-Associated (Cas) Genes Price by Type (2016-2021)
4.3.2 Global CRISPR and CRISPR-Associated (Cas) Genes Price Forecast by Type (2022-2027) 5 Market Size by Application 5.1 Global CRISPR and CRISPR-Associated (Cas) Genes Sales by Application
5.1.1 Global CRISPR and CRISPR-Associated (Cas) Genes Historical Sales by Application (2016-2021)
5.1.2 Global CRISPR and CRISPR-Associated (Cas) Genes Forecasted Sales by Application (2022-2027)
5.1.3 Global CRISPR and CRISPR-Associated (Cas) Genes Sales Market Share by Application (2016-2027) 5.2 Global CRISPR and CRISPR-Associated (Cas) Genes Revenue by Application
5.2.1 Global CRISPR and CRISPR-Associated (Cas) Genes Historical Revenue by Application (2016-2021)
5.2.2 Global CRISPR and CRISPR-Associated (Cas) Genes Forecasted Revenue by Application (2022-2027)
5.2.3 Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Application (2016-2027) 5.3 Global CRISPR and CRISPR-Associated (Cas) Genes Price by Application
5.3.1 Global CRISPR and CRISPR-Associated (Cas) Genes Price by Application (2016-2021)
5.3.2 Global CRISPR and CRISPR-Associated (Cas) Genes Price Forecast by Application (2022-2027) 6 North America 6.1 North America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type
6.1.1 North America CRISPR and CRISPR-Associated (Cas) Genes Sales by Type (2016-2027)
6.1.2 North America CRISPR and CRISPR-Associated (Cas) Genes Revenue by Type (2016-2027) 6.2 North America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application
6.2.1 North America CRISPR and CRISPR-Associated (Cas) Genes Sales by Application (2016-2027)
6.2.2 North America CRISPR and CRISPR-Associated (Cas) Genes Revenue by Application (2016-2027) 6.3 North America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country
6.3.1 North America CRISPR and CRISPR-Associated (Cas) Genes Sales by Country (2016-2027)
6.3.2 North America CRISPR and CRISPR-Associated (Cas) Genes Revenue by Country (2016-2027)
6.3.3 U.S.
6.3.4 Canada 7 Europe 7.1 Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type
7.1.1 Europe CRISPR and CRISPR-Associated (Cas) Genes Sales by Type (2017-2027)
7.1.2 Europe CRISPR and CRISPR-Associated (Cas) Genes Revenue by Type (2017-2027) 7.2 Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application
7.2.1 Europe CRISPR and CRISPR-Associated (Cas) Genes Sales by Application (2017-2027)
7.2.2 Europe CRISPR and CRISPR-Associated (Cas) Genes Revenue by Application (2017-2027) 7.3 Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country
7.3.1 Europe CRISPR and CRISPR-Associated (Cas) Genes Sales by Country (2017-2027)
7.3.2 Europe CRISPR and CRISPR-Associated (Cas) Genes Revenue by Country (2017-2027)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia 8 Asia Pacific 8.1 Asia Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type
8.1.1 Asia Pacific CRISPR and CRISPR-Associated (Cas) Genes Sales by Type (2018-2027)
8.1.2 Asia Pacific CRISPR and CRISPR-Associated (Cas) Genes Revenue by Type (2018-2027) 8.2 Asia Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application
8.2.1 Asia Pacific CRISPR and CRISPR-Associated (Cas) Genes Sales by Application (2018-2027)
8.2.2 Asia Pacific CRISPR and CRISPR-Associated (Cas) Genes Revenue by Application (2018-2027) 8.3 Asia Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size by Region
8.3.1 Asia Pacific CRISPR and CRISPR-Associated (Cas) Genes Sales by Region (2018-2027)
8.3.2 Asia Pacific CRISPR and CRISPR-Associated (Cas) Genes Revenue by Region (2018-2027)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines 9 Latin America 9.1 Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type
9.1.1 Latin America CRISPR and CRISPR-Associated (Cas) Genes Sales by Type (2019-2027)
9.1.2 Latin America CRISPR and CRISPR-Associated (Cas) Genes Revenue by Type (2019-2027) 9.2 Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application
9.2.1 Latin America CRISPR and CRISPR-Associated (Cas) Genes Sales by Application (2019-2027)
9.2.2 Latin America CRISPR and CRISPR-Associated (Cas) Genes Revenue by Application (2019-2027) 9.3 Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country
9.3.1 Latin America CRISPR and CRISPR-Associated (Cas) Genes Sales by Country (2019-2027)
9.3.2 Latin America CRISPR and CRISPR-Associated (Cas) Genes Revenue by Country (2019-2027)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina 6 Middle East and Africa 6.1 Middle East and Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type
6.1.1 Middle East and Africa CRISPR and CRISPR-Associated (Cas) Genes Sales by Type (2016-2027)
6.1.2 Middle East and Africa CRISPR and CRISPR-Associated (Cas) Genes Revenue by Type (2016-2027) 6.2 Middle East and Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application
6.2.1 Middle East and Africa CRISPR and CRISPR-Associated (Cas) Genes Sales by Application (2016-2027)
6.2.2 Middle East and Africa CRISPR and CRISPR-Associated (Cas) Genes Revenue by Application (2016-2027) 6.3 Middle East and Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country
6.3.1 Middle East and Africa CRISPR and CRISPR-Associated (Cas) Genes Sales by Country (2016-2027)
6.3.2 Middle East and Africa CRISPR and CRISPR-Associated (Cas) Genes Revenue by Country (2016-2027)
6.3.3 Turkey
6.3.4 Saudi Arabia
6.3.5 U.A.E 11 Company Profiles 11.1 Caribou Biosciences
11.1.1 Caribou Biosciences Corporation Information
11.1.2 Caribou Biosciences Overview
11.1.3 Caribou Biosciences CRISPR and CRISPR-Associated (Cas) Genes Sales, Price, Revenue and Gross Margin (2016-2021)
11.1.4 Caribou Biosciences CRISPR and CRISPR-Associated (Cas) Genes Product Description
11.1.5 Caribou Biosciences Related Developments 11.2 Addgene
11.2.1 Addgene Corporation Information
11.2.2 Addgene Overview
11.2.3 Addgene CRISPR and CRISPR-Associated (Cas) Genes Sales, Price, Revenue and Gross Margin (2016-2021)
11.2.4 Addgene CRISPR and CRISPR-Associated (Cas) Genes Product Description
11.2.5 Addgene Related Developments 11.3 CRISPR THERAPEUTICS
11.3.1 CRISPR THERAPEUTICS Corporation Information
11.3.2 CRISPR THERAPEUTICS Overview
11.3.3 CRISPR THERAPEUTICS CRISPR and CRISPR-Associated (Cas) Genes Sales, Price, Revenue and Gross Margin (2016-2021)
11.3.4 CRISPR THERAPEUTICS CRISPR and CRISPR-Associated (Cas) Genes Product Description
11.3.5 CRISPR THERAPEUTICS Related Developments 11.4 Merck KGaA
11.4.1 Merck KGaA Corporation Information
11.4.2 Merck KGaA Overview
11.4.3 Merck KGaA CRISPR and CRISPR-Associated (Cas) Genes Sales, Price, Revenue and Gross Margin (2016-2021)
11.4.4 Merck KGaA CRISPR and CRISPR-Associated (Cas) Genes Product Description
11.4.5 Merck KGaA Related Developments 11.5 Mirus Bio LLC
11.5.1 Mirus Bio LLC Corporation Information
11.5.2 Mirus Bio LLC Overview
11.5.3 Mirus Bio LLC CRISPR and CRISPR-Associated (Cas) Genes Sales, Price, Revenue and Gross Margin (2016-2021)
11.5.4 Mirus Bio LLC CRISPR and CRISPR-Associated (Cas) Genes Product Description
11.5.5 Mirus Bio LLC Related Developments 11.6 Editas Medicine
11.6.1 Editas Medicine Corporation Information
11.6.2 Editas Medicine Overview
11.6.3 Editas Medicine CRISPR and CRISPR-Associated (Cas) Genes Sales, Price, Revenue and Gross Margin (2016-2021)
11.6.4 Editas Medicine CRISPR and CRISPR-Associated (Cas) Genes Product Description
11.6.5 Editas Medicine Related Developments 11.7 Takara Bio USA
11.7.1 Takara Bio USA Corporation Information
11.7.2 Takara Bio USA Overview
11.7.3 Takara Bio USA CRISPR and CRISPR-Associated (Cas) Genes Sales, Price, Revenue and Gross Margin (2016-2021)
11.7.4 Takara Bio USA CRISPR and CRISPR-Associated (Cas) Genes Product Description
11.7.5 Takara Bio USA Related Developments 11.8 Thermo Fisher Scientific
11.8.1 Thermo Fisher Scientific Corporation Information
11.8.2 Thermo Fisher Scientific Overview
11.8.3 Thermo Fisher Scientific CRISPR and CRISPR-Associated (Cas) Genes Sales, Price, Revenue and Gross Margin (2016-2021)
11.8.4 Thermo Fisher Scientific CRISPR and CRISPR-Associated (Cas) Genes Product Description
11.8.5 Thermo Fisher Scientific Related Developments 11.9 Horizon Discovery Group
11.9.1 Horizon Discovery Group Corporation Information
11.9.2 Horizon Discovery Group Overview
11.9.3 Horizon Discovery Group CRISPR and CRISPR-Associated (Cas) Genes Sales, Price, Revenue and Gross Margin (2016-2021)
11.9.4 Horizon Discovery Group CRISPR and CRISPR-Associated (Cas) Genes Product Description
11.9.5 Horizon Discovery Group Related Developments 11.10 Intellia Therapeutics
11.10.1 Intellia Therapeutics Corporation Information
11.10.2 Intellia Therapeutics Overview
11.10.3 Intellia Therapeutics CRISPR and CRISPR-Associated (Cas) Genes Sales, Price, Revenue and Gross Margin (2016-2021)
11.10.4 Intellia Therapeutics CRISPR and CRISPR-Associated (Cas) Genes Product Description
11.10.5 Intellia Therapeutics Related Developments 11.1 Caribou Biosciences
11.1.1 Caribou Biosciences Corporation Information
11.1.2 Caribou Biosciences Overview
11.1.3 Caribou Biosciences CRISPR and CRISPR-Associated (Cas) Genes Sales, Price, Revenue and Gross Margin (2016-2021)
11.1.4 Caribou Biosciences CRISPR and CRISPR-Associated (Cas) Genes Product Description
11.1.5 Caribou Biosciences Related Developments 12 Value Chain and Sales Channels Analysis 12.1 CRISPR and CRISPR-Associated (Cas) Genes Value Chain Analysis 12.2 CRISPR and CRISPR-Associated (Cas) Genes Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers 12.3 CRISPR and CRISPR-Associated (Cas) Genes Production Mode & Process 12.4 CRISPR and CRISPR-Associated (Cas) Genes Sales and Marketing
12.4.1 CRISPR and CRISPR-Associated (Cas) Genes Sales Channels
12.4.2 CRISPR and CRISPR-Associated (Cas) Genes Distributors 12.5 CRISPR and CRISPR-Associated (Cas) Genes Customers 13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis 13.1 CRISPR and CRISPR-Associated (Cas) Genes Industry Trends 13.2 CRISPR and CRISPR-Associated (Cas) Genes Market Drivers 13.3 CRISPR and CRISPR-Associated (Cas) Genes Market Challenges 13.4 CRISPR and CRISPR-Associated (Cas) Genes Market Restraints 14 Key Findings in The Global CRISPR and CRISPR-Associated (Cas) Genes Study 15 Appendix 15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source 15.2 Author Details 15.3 Disclaimer

 About Us

QY Research is a leading global market research and consulting company. Established in 2007 QY Research focuses on management consulting, database and seminar services, IPO consulting, industry chain research and custom research to help our clients in providing non-linear revenue model and make them successful. We are globally recognized for our expansive portfolio of services, good corporate citizenship and our strong commitment to sustainability. Today, we are serving more than 4000 clients across five continents. Let�s allow us to work closely with you and build a bold and a better future.

 

jumbonews.co.uk/



Source link